FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Toxic Risk with Fresenius Hemodialysis Machines: FDA

FDA warns about the potential risk of exposure to toxic non-dioxin-like polychlorinated biphenyl acids and polychlorinated biphenyls with certain Fres...

Federal Register

Info Collection on Investigational Device Exemptions

Federal Register notice: FDA seeks comments on an information collection extension entitled Investigational Device Exemptions 21 CFR Part 812.

Medical Devices

Device Guidance on Voluntary Improvement Program

FDA releases a draft guidance entitled Fostering Medical Device Improvement: FDA Activities and Engagement with the Voluntary Improvement Program.

Human Drugs

Myovant, Pfizer Myfembree sNDA Review Extended

Citing the need to assess just-submitted bone mineral density data, FDA extends its review of a Myovant Sciences and Pfizer supplemental NDA for Myfem...

Federal Register

Diabetes Device Feasibility Studies Guidance

Federal Register notice: FDA makes available a final guidance entitled Feasibility and Early Feasibility Clinical Studies for Certain Medical Devices ...

Medical Devices

Increase FDA Oversight of Lab-developed Tests: Pew

A new Pew Charitable Trusts survey on lab-developed tests finds that most participants would favor increased FDA oversight in this space.

Human Drugs

Califf Returned to FDA for Unfinished Business

FDA commissioner Robert Califf admits that his return to the FDA top post gives him an opportunity to address unfinished business from the first time ...

Medical Devices

Lasik Injury Advocate Steps Up Pressure on Illegal Ads

Lasik injury advocate and Vision Advocacy president Paula Cofer steps up pressure to get FDA commissioner Robert Califfs attention to address illegal ...

Human Drugs

CDER Study Verifies Continuous Manufacturing Benefits

Eleven CDER staffers say a Center self-audit of continuous manufacturing regulatory submissions verifies the benefits the agency has seen in such tech...

Human Drugs

FDA Approves Enhertu for Some Additional Breast Cancers

FDA approves a new indication for Daiichi Sankyos Enhertu for some breast cancer patients.